Clinical Trials in Baltimore

Showing 2661-2680 of 20,142 trials

A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

NCT05360680

This is a Phase 1, open-label, 2-part, multi-center study evaluating the safety, tolerability, PK, pharmacodynamics (PD), immunogenicity, and antitumor activity of CUE-102 intravenous (IV) monotherapy in HLA-A\*0201 positive patients with WT1 positive recurrent/metastatic solid tumors who have failed conventional therapies.

Colorectal CancerGastric CancerPancreatic Cancer+1 more

Cue Biopharma42 participantsStarted Jun 2022

Phoenix, Arizona, United States • Los Angeles, California, United States • Palo Alto, California, United States +12 more locations

TERMINATEDNA< 1 mile

Radiosurgical Hypophysectomy for Bone Metasteses Pain

NCT03377517

This research is being done to see if a delivery of a single high dose of radiation therapy to a small area of the pituitary gland and pituitary stalk in a highly precise manner may be helpful in reducing intractable pain from bone metastases.

Bone Metastases

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5 participantsStarted May 2018

Baltimore, Maryland, United States

A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

Radiosurgical Hypophysectomy for Bone Metasteses Pain

Find Trials by Condition in Baltimore

A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B

A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

DBT Skills Groups for Veterans at High Risk for Suicide Attempt

JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation

Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors

Learning Study: Improving Vision in Adults With Macular Degeneration